Cytodiagnostics Inc

Cytodiagnostics Inc is a biotechnology and diagnostics company with headquarters in Burlington, ON, Canada, and Tulsa, OK, USA, and a Research and Development Position at the Innovate Calgary Life Science Hub at the University of Calgary. Established in 2009, the company has become a leading global supplier of gold and silver nanoparticles, offering quality materials and expertise in particle behavior, synthesis, functionalization, and detection molecule conjugation.

The company's focus on incorporating nanoparticles into diagnostic tests has led to the creation of CytoGROUP, a division dedicated to providing high-quality lab-based and point-of-care diagnostics. Leveraging chemical modifications, antibody, and cutting-edge nucleic acid/aptamer detection molecules, Cytodiagnostics offers a range of products such as lateral flow tests, plate-based assays, along with custom diagnostic test development services.

With expertise in lateral flow and vertical flow assays, ELISA, ELASA, and Aptamer Development, Cytodiagnostics' associate company, CytoGroup, provides both products and development services, catering to the needs of the biotechnology and healthcare industries. The company's overarching goal is to support customer success in research and development efforts by delivering the highest quality products.

Cytodiagnostics Inc presents a compelling investment opportunity, offering a strong foothold in the biotechnology and diagnostics sectors with a proven track record of innovation and global reach. The company's dedication to quality, coupled with its diverse product offerings and custom development services, positions it as an attractive prospect for investors seeking exposure to the burgeoning life sciences and nanotechnology markets.